2005, Number 3
<< Back Next >>
Gac Med Mex 2005; 141 (3)
A 42 year-old woman with ascitis and presence of generalized linfadenopathy.
Lopez-Krauletz S, Nellen-Hummel H, Jacobo-Rubalcava A, Iparraguirre-Palomeque V, Flores-Figueroa F, Ayala-Hernández I, Halabe-Cherem J
Language: Spanish
References: 9
Page: 223-226
PDF size: 62.86 Kb.
Text Extraction
No Abstract
REFERENCES
Herrada J, Cabanillas F, Rice L, et al. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 1998;128(8):657-662.
Frizzera G, Bayrd E, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman’s disease: clinical findings and clinicopathologic corelations in 15 patients. JCO 1985;3(9):1202-1216.
Ahmed R, Adhami N, Hanif M, et al. Unicentric Castleman disease; a case report and review of literature. Chest 1999;116(4):410S.
Maslovsky I, Uriev L, Lugassy G. The heterogeneity of Castleman disease: Report of five cases and review of literature. Am J Med Scien 2000;320(4):292-295.
Kinoshita T, Ishii K, Mori Y, et al. Castleman disease in the anterior neck: the role of Ga-67 scintigraphy. Clin Nucl Med 1996;21(8):626-628.
Belec L, Hallouin M, Authier F, et al. Human herpesvirus 8 DNA sequences with restricted variability in ORF26 in patients with POEMS syndrome-asociated Castleman’s disease. Neurology 1998;504(4):A184S.
Zeidman A, Fradin Z, Cohen A, et al. Kaposi’s sarcoma associated with Castleman’s disease. Eur J Haematol 1999;63(1):67-70.
Kazes I, Deray G, Jacobs C. Castleman disease and renal amyloidosis. Ann Intern Med 1995;122(5):395-396.
Norihiro N, Mitsuko S, Yoshihito S, et al. Improvement in Castleman’s disease by humanized anti-interleukin-6 receptor antibody theraphy. Blood 2000;95(1):56-61.
Full text